Risk Factors for Medically Treated Hypocalcemia after Surgery for Graves’ Disease: A Swedish Multicenter Study of 1,157 Patients
- 4 April 2012
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 36 (8), 1933-1942
- https://doi.org/10.1007/s00268-012-1574-4
Abstract
For reasons that remain unclear, surgery for Graves’ disease is associated with a higher risk of hypocalcemia than surgery for benign atoxic goiter. In the present study, we evaluated risk factors for postoperative hypocalcemia in patients undergoing operation for Graves’ disease. Data from 1,157 patients who underwent operation for Graves’ disease between 2004 and 2008 were extracted from the Scandinavian database for Thyroid and Parathyroid Surgery. Risk factors for postoperative hypocalcemia (in-hospital i. v. calcium; treatment with vitamin D analog at discharge, at 6 weeks, and at 6 months postoperatively) were evaluated by logistic regression analysis. Risk factors for i. v. calcium were low hospital volume of thyroid surgery (odds ratio [OR]: 95 % confidence interval [95 % CI], 0.99: 0.99–1.00), age (0.95: 0.91–1.00), operative time (1.02: 1.01–1.02), university hospital (12.91: 2.68–62.30), and reoperation for bleeding (10.32: 1.51–70.69). The risk for treatment with vitamin D at discharge increased with operative time (1.01: 1.00–1.02), excised gland weight (1.01: 1.00–1.01), parathyroid autotransplantation (5.19: 2.28–11.84), and reoperation for bleeding (12.00: 2.43–59.28). At 6 weeks, vitamin D medication was associated with gland weight (1.00: 1.00–1.01), and preoperative medication with β-blockers (4.20: 1.67–10.55). At 6 months, vitamin D medication was associated with gland weight (1.00: 1.00–1.01) and reoperation for bleeding (10.59: 1.58–71.22). Risk factors for medically treated hypocalcemia varied at different times of follow-up. Young age, operative time, type of hospital, and parathyroid autotransplantation were associated with early postoperatively hypocalcemia. Preoperative β-blocker treatment was a risk factor at the first follow-up. At early and late follow-up, gland weight and reoperation for bleeding were associated with medically treated hypocalcemia.Keywords
This publication has 30 references indexed in Scilit:
- Postoperative Hypocalcemia After Thyroidectomy for Graves' DiseaseThyroid®, 2010
- Outcome of protracted hypoparathyroidism after total thyroidectomyBritish Journal of Surgery, 2010
- Complications in primary and completed thyroidectomySurgery Today, 2010
- Kinetics of serum parathyroid hormone during and after thyroid surgeryBritish Journal of Surgery, 2008
- Thyroidectomy and parathyroid hormone: tracing hypocalcemia-prone patientsThe American Journal of Surgery, 2008
- Severe Graves' Ophthalmopathy may be a Risk Factor for the Development of Postthyroidectomy HypocalcaemiaExperimental and Clinical Endocrinology & Diabetes, 2008
- Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgerySurgery, 2007
- Graves' Disease with Moderate–Severe Endocrine Ophthalmopathy–Long Term Results of a Prospective, Randomized Study of Total or Subtotal Thyroid ResectionThyroid®, 2005
- Assessment of parathyroid autotransplantation for preservation of parathyroid function after total thyroidectomyHead & Neck, 2003
- Total thyroidectomy for benign thyroid diseaseSurgery, 1998